Altamira Therapeutics Ltd. Made Headway

Wed, Dec 06, 2023 at 07:41 PM

Altamira Therapeutics Ltd. (CYTO:NASDAQ) shot up at $0.56, representing a gain of 54.7%. The stock got featured on our News Catalysts scanner on Tue, Dec 05, 2023 at 02:53 PM in the 'MISCELLANEOUS' category. From Fri, Nov 24, 2023, the stock recorded 50.00% Up Days and 44.44% Green Days

The stock spiked on Thu, Nov 30, 2023 at $0.86 with a volume of 69M+.

About Altamira Therapeutics Ltd. (CYTO:NASDAQ)

Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders.

Top 10 Gainers:

Kubient Inc. (KBNT:NASDAQ), 2757.14%
MicroAlgo Inc. (MLGO:NASDAQ), 295.87%
Sera Prognostics Inc. (SERA:NASDAQ), 153%
Tempo Automation Holdings Inc. (TMPO:NASDAQ), 150%
SRAX, Inc. (SRAX:NASDAQ), 100%
Signature Bank (SBNY:NASDAQ), 80%
Altamira Therapeutics Ltd. (CYTO:NASDAQ), 54.7%
Leju Holdings Limited (LEJU:NYSE), 51.57%
Troika Media Group Inc. (TRKA:NASDAQ), 44.7%
Pineapple Financial Inc. (PAPL:NYSEMKT), 43.29%